Literature DB >> 31930160

A Radioactive in vitro ERK3 Kinase Assay.

Lobna Elkhadragy1,2, Weiwen Long1.   

Abstract

Mitogen-activated protein kinases (MAPKs) are serine/threonine kinases that have an important role in signal transduction. Extracellular signal-regulated kinase 3 (ERK3), also known as MAPK6, is an atypical MAPK. Here, we describe in detail an in vitro assay for the kinase activity of ERK3 using myelin basic protein (MBP) or steroid receptor coactivator-3 (SRC-3) as substrates. The assay is carried out in the presence of [y-32P]-ATP which results in radiolabeling of phosphorylated substrates. Separation of the reaction components by gel electrophoresis followed by autoradiography enables detection of the radiolabeled products, and hence determination of the kinase activity of ERK3. This assay can be used for several applications including identification of substrates, determination of the effect of molecules or mutations on kinase activity, and testing specific kinase inhibitors. Furthermore, the protocol outlined here can be adapted to measure the activity of other kinases by using their specific substrates.

Entities:  

Keywords:  32P-ATP; ERK3; Kinase assay; MAPK; Radioactive assay

Year:  2019        PMID: 31930160      PMCID: PMC6953734          DOI: 10.21769/BioProtoc.3332

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  9 in total

1.  Activation loop phosphorylation of ERK3 is important for its kinase activity and ability to promote lung cancer cell invasiveness.

Authors:  Lobna Elkhadragy; Hadel Alsaran; Marion Morel; Weiwen Long
Journal:  J Biol Chem       Date:  2018-08-30       Impact factor: 5.157

2.  ERK3 is a constitutively nuclear protein kinase.

Authors:  M Cheng; T G Boulton; M H Cobb
Journal:  J Biol Chem       Date:  1996-04-12       Impact factor: 5.157

3.  ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion.

Authors:  Weiwen Long; Charles E Foulds; Jun Qin; Jian Liu; Chen Ding; David M Lonard; Luisa M Solis; Ignacio I Wistuba; Jun Qin; Sophia Y Tsai; Ming-Jer Tsai; Bert W O'Malley
Journal:  J Clin Invest       Date:  2012-04-16       Impact factor: 14.808

4.  Scaffolding by ERK3 regulates MK5 in development.

Authors:  Stefanie Schumacher; Kathrin Laass; Shashi Kant; Yu Shi; Axel Visel; Achim D Gruber; Alexey Kotlyarov; Matthias Gaestel
Journal:  EMBO J       Date:  2004-11-11       Impact factor: 11.598

Review 5.  Atypical mitogen-activated protein kinases: structure, regulation and functions.

Authors:  Phillipe Coulombe; Sylvain Meloche
Journal:  Biochim Biophys Acta       Date:  2006-11-07

6.  Activation of MK5/PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway.

Authors:  Ole-Morten Seternes; Theresa Mikalsen; Bjarne Johansen; Espen Michaelsen; Chris G Armstrong; Nick A Morrice; Benjamin Turgeon; Sylvain Meloche; Ugo Moens; Stephen M Keyse
Journal:  EMBO J       Date:  2004-12-02       Impact factor: 11.598

Review 7.  Enzyme Activity Assays for Protein Kinases: Strategies to Identify Active Substrates.

Authors:  Brad A Haubrich; David C Swinney
Journal:  Curr Drug Discov Technol       Date:  2016

8.  ERK3 regulates TDP2-mediated DNA damage response and chemoresistance in lung cancer cells.

Authors:  Ka Bian; Naveen Reddy Muppani; Lobna Elkhadragy; Wei Wang; Cheng Zhang; Tenghui Chen; Sungyun Jung; Ole Morten Seternes; Weiwen Long
Journal:  Oncotarget       Date:  2016-02-09

9.  L290P/V mutations increase ERK3's cytoplasmic localization and migration/invasion-promoting capability in cancer cells.

Authors:  Hadel Alsaran; Lobna Elkhadragy; Astha Shakya; Weiwen Long
Journal:  Sci Rep       Date:  2017-11-03       Impact factor: 4.379

  9 in total
  1 in total

1.  The C-Terminus Tail Regulates ERK3 Kinase Activity and Its Ability in Promoting Cancer Cell Migration and Invasion.

Authors:  Lobna Elkhadragy; Hadel Alsaran; Weiwen Long
Journal:  Int J Mol Sci       Date:  2020-06-05       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.